{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:41:16Z","timestamp":1790847676935,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX004349"],"award-info":[{"award-number":["BX004349"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX002466"],"award-info":[{"award-number":["BX002466"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Aging","award":["P30AG072978"],"award-info":[{"award-number":["P30AG072978"]}]},{"name":"National Institute of Aging","award":["F31NS127449"],"award-info":[{"award-number":["F31NS127449"]}]},{"name":"National Institute of Aging","award":["P30AG062677"],"award-info":[{"award-number":["P30AG062677"]}]},{"name":"National Institute of Aging","award":["P30AG072978"],"award-info":[{"award-number":["P30AG072978"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54NS115266"],"award-info":[{"award-number":["U54NS115266"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG062348"],"award-info":[{"award-number":["R01AG062348"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tauopathies are a group of neurodegenerative diseases where there is pathologic accumulation of hyperphosphorylated tau protein (ptau). The most common tauopathy is Alzheimer\u2019s disease (AD), but chronic traumatic encephalopathy (CTE), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and argyrophilic grain disease (AGD) are significant health risks as well. Currently, it is unclear what specific molecular factors might drive each distinct disease and represent therapeutic targets. Additionally, there is a lack of biomarkers that can differentiate each disease in life. Recent work has suggested that neuroinflammatory changes might be specific among distinct diseases and offers a novel resource for mechanistic targets and biomarker candidates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To better examine each tauopathy, a 71 immune-related protein multiplex ELISA panel was utilized to analyze anterior cingulate grey matter from 127 individuals neuropathologically diagnosed with AD, CTE, PSP, CBD, and AGD. A partial least square regression analysis was carried out to perform unbiased clustering and identify proteins that are distinctly correlated with each tauopathy correcting for age and gender. Receiver operator characteristic and binary logistic regression analyses were then used to examine the ability of each candidate protein to distinguish diseases. Validation in postmortem cerebrospinal fluid (CSF) from 15 AD and 14 CTE cases was performed to determine if candidate proteins could act as possible novel biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five clusters of immune proteins were identified and compared to each tauopathy to determine if clusters were specific to distinct disease. Each cluster was found to correlate with either CTE, AD, PSP, CBD, or AGD. When examining which proteins were the strongest driver of each cluster, it was observed the most distinctive protein for CTE was CCL21, AD was FLT3L, and PSP was IL13. Individual proteins that were specific to CBD and AGD were not observed. CCL21 was observed to be elevated in CTE CSF compared to AD cases (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02), further validating the use as possible biomarkers. Sub-analyses for male only cases confirmed the results were not skewed by gender differences.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, these results highlight that different neuroinflammatory responses might underlie unique mechanisms in related neurodegenerative pathologies. Additionally, the use of distinct neuroinflammatory signatures could help differentiate between tauopathies and act as novel biomarker candidate to increase specificity for in-life diagnoses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-022-02640-6","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T04:03:59Z","timestamp":1668830639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Neuroimmune proteins can differentiate between tauopathies"],"prefix":"10.1186","volume":"19","author":[{"given":"Jonathan D.","family":"Cherry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach H.","family":"Baucom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaleb G.","family":"Eppich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin R.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorghos","family":"Tripodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin F.","family":"Bieniek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Whitney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Uretsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Crary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann C.","family":"McKee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"key":"2640_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainresbull.2016.08.018","volume":"126","author":"T Arendt","year":"2016","unstructured":"Arendt T, Stieler JT, Holzer M. Tau and tauopathies. Brain Res Bull. 2016;126:238\u201392.","journal-title":"Brain Res Bull"},{"key":"2640_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","volume":"9","author":"IG McKeith","year":"2006","unstructured":"McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis. 2006;9:417\u201323.","journal-title":"J Alzheimers Dis"},{"key":"2640_CR3","doi-asserted-by":"publisher","DOI":"10.1201\/b22602","volume-title":"Greenfield\u2019s neuropathology, 2-volume set","author":"S Love","year":"2008","unstructured":"Love S, Louis D, Ellison DW. Greenfield\u2019s neuropathology, 2-volume set. 8th ed. Boca Raton: CRC Press; 2008.","edition":"8"},{"key":"2640_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","volume":"119","author":"IR Mackenzie","year":"2010","unstructured":"Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, Kovacs GG, Ghetti B, Halliday G, Holm IE, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010;119:1\u20134.","journal-title":"Acta Neuropathol"},{"key":"2640_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol. 2012;123:1\u201311.","journal-title":"Acta Neuropathol"},{"key":"2640_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-015-1515-z","volume":"131","author":"AC McKee","year":"2015","unstructured":"McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Dirk Keene C, Litvan I, Perl DP, Stein TD, Vonsattel J-P, Stewart W, et al. The first NINDS\/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2015;131:75\u201386.","journal-title":"Acta Neuropathol"},{"key":"2640_CR7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/jnen\/nlab066.001","volume":"80","author":"KF Bieniek","year":"2021","unstructured":"Bieniek KF, Cairns NJ, Crary JF, Dickson DW, Folkerth RD, Keene CD, Litvan I, Perl DP, Stein TD, Vonsattel JP, et al. The second NINDS\/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. J Neuropathol Exp Neurol. 2021;80:210\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2640_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00401-022-02479-4","volume":"144","author":"SF Roemer","year":"2022","unstructured":"Roemer SF, Grinberg LT, Crary JF, Seeley WW, McKee AC, Kovacs GG, Beach TG, Duyckaerts C, Ferrer IA, Gelpi E, et al. Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy. Acta Neuropathol. 2022;144:603\u201314.","journal-title":"Acta Neuropathol"},{"key":"2640_CR9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/jnen\/nlac065","volume":"81","author":"M Butler","year":"2022","unstructured":"Butler M, Dixon E, Stein TD, Alvarez VE, Huber B, Buckland ME, McKee AC, Cherry JD. Tau pathology in chronic traumatic encephalopathy is primarily neuronal. J Neuropathol Exp Neurol. 2022;81:773\u201380.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2640_CR10","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jalz.2018.05.004","volume":"14","author":"ML Alosco","year":"2018","unstructured":"Alosco ML, Tripodis Y, Fritts NG, Heslegrave A, Baugh CM, Conneely S, Mariani M, Martin BM, Frank S, Mez J, et al. Cerebrospinal fluid tau, Abeta, and sTREM2 in Former National Football League Players: modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration. Alzheimers Dement. 2018;14:1159\u201370.","journal-title":"Alzheimers Dement"},{"key":"2640_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13195-022-00976-y","volume":"14","author":"KW Turk","year":"2022","unstructured":"Turk KW, Geada A, Alvarez VE, Xia W, Cherry JD, Nicks R, Meng G, Daley S, Tripodis Y, Huber BR, et al. A comparison between tau and amyloid-beta cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease. Alzheimers Res Ther. 2022;14:28.","journal-title":"Alzheimers Res Ther"},{"key":"2640_CR12","doi-asserted-by":"publisher","first-page":"103837","DOI":"10.1016\/j.ebiom.2022.103837","volume":"76","author":"C Tissot","year":"2022","unstructured":"Tissot C, Therriault J, Kunach P, Benedet AL, Pascoal TA, Ashton NJ, Karikari TK, Servaes S, Lussier FZ, Chamoun M, et al. Comparing tau status determined via plasma pTau181, pTau231 and [(18)F]MK6240 tau-PET. EBioMedicine. 2022;76:103837.","journal-title":"EBioMedicine"},{"key":"2640_CR13","doi-asserted-by":"crossref","unstructured":"Paolicelli R, Sierra A, Stevens B, Temblay ME, Aguzzi A, Ajami B, Amit I, Audinat E, Bechmann I, Bennett M, et al. Defining microglial states and nomenclature: a roadmap to 2030. Cell. 2022, Preprint. Available at SSRN: https:\/\/ssrn.com\/abstract=4065080.","DOI":"10.2139\/ssrn.4065080"},{"key":"2640_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin C, Galea E, Lakatos A, O\u2019Callaghan JP, Petzold GC, Serrano-Pozo A, Steinhauser C, Volterra A, Carmignoto G, Agarwal A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24:312\u20135.","journal-title":"Nat Neurosci"},{"key":"2640_CR15","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1038\/s41467-020-19737-2","volume":"11","author":"M Olah","year":"2020","unstructured":"Olah M, Menon V, Habib N, Taga MF, Ma Y, Yung CJ, Cimpean M, Khairallah A, Coronas-Samano G, Sankowski R, et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease. Nat Commun. 2020;11:6129.","journal-title":"Nat Commun"},{"key":"2640_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00401-021-02322-2","volume":"142","author":"KB Chancellor","year":"2021","unstructured":"Chancellor KB, Chancellor SE, Duke-Cohan JE, Huber BR, Stein TD, Alvarez VE, Okaty BW, Dymecki SM, McKee AC. Altered oligodendroglia and astroglia in chronic traumatic encephalopathy. Acta Neuropathol. 2021;142:295\u2013321.","journal-title":"Acta Neuropathol"},{"key":"2640_CR17","doi-asserted-by":"crossref","unstructured":"Sharma A, Song W-M, Farrell K, Whitney K, Zhang B, Crary JF, Pereira AC. Single-cell atlas of progressive supranuclear palsy reveals a distinct hybrid glial cell population. bioRxiv 2021.","DOI":"10.1101\/2021.04.11.439393"},{"key":"2640_CR18","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.neuron.2022.03.008","volume":"110","author":"JS Sadick","year":"2022","unstructured":"Sadick JS, O\u2019Dea MR, Hasel P, Dykstra T, Faustin A, Liddelow SA. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer\u2019s disease. Neuron. 2022;110:1788.","journal-title":"Neuron"},{"key":"2640_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185541","volume":"12","author":"JD Cherry","year":"2017","unstructured":"Cherry JD, Stein TD, Tripodis Y, Alvarez VE, Huber BR, Au R, Kiernan PT, Daneshvar DH, Mez J, Solomon TM, et al. CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer\u2019s disease. PLoS ONE. 2017;12: e0185541.","journal-title":"PLoS ONE"},{"key":"2640_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10357","volume":"477","author":"SA Villeda","year":"2011","unstructured":"Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011;477:90\u20134.","journal-title":"Nature"},{"key":"2640_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12974-020-02036-4","volume":"17","author":"JD Cherry","year":"2020","unstructured":"Cherry JD, Meng G, Daley S, Xia W, Svirsky S, Alvarez VE, Nicks R, Pothast M, Kelley H, Huber B, et al. CCL2 is associated with microglia and macrophage recruitment in chronic traumatic encephalopathy. J Neuroinflam. 2020;17:370.","journal-title":"J Neuroinflam"},{"key":"2640_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/brain\/aws307","volume":"136","author":"AC McKee","year":"2013","unstructured":"McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH, Lee HS, Wojtowicz SM, Hall G, Baugh CM, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013;136:43\u201364.","journal-title":"Brain"},{"key":"2640_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ana.72","volume":"49","author":"S Tekin","year":"2001","unstructured":"Tekin S, Mega MS, Masterman DM, Chow T, Garakian J, Vinters HV, Cummings JL. Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol. 2001;49:355\u201361.","journal-title":"Ann Neurol"},{"key":"2640_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5414\/NPP29271","volume":"29","author":"GG Kovacs","year":"2010","unstructured":"Kovacs GG, Budka H. Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases. Clin Neuropathol. 2010;29:271\u201388.","journal-title":"Clin Neuropathol"},{"key":"2640_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/jnen\/nlz141","volume":"79","author":"JL Robinson","year":"2020","unstructured":"Robinson JL, Yan N, Caswell C, Xie SX, Suh E, Van Deerlin VM, Gibbons G, Irwin DJ, Grossman M, Lee EB, et al. Primary tau pathology, not copathology, correlates with clinical symptoms in PSP and CBD. J Neuropathol Exp Neurol. 2020;79:296\u2013304.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2640_CR26","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/brain\/awm305","volume":"131","author":"I Ferrer","year":"2008","unstructured":"Ferrer I, Santpere G, van Leeuwen FW. Argyrophilic grain disease. Brain. 2008;131:1416\u201332.","journal-title":"Brain"},{"key":"2640_CR27","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/bpa.12867","volume":"30","author":"JD Cherry","year":"2020","unstructured":"Cherry JD, Kim SH, Stein TD, Pothast MJ, Nicks R, Meng G, Huber BR, Mez J, Alosco ML, Tripodis Y, et al. Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy. Brain Pathol. 2020;30:913\u201325.","journal-title":"Brain Pathol"},{"key":"2640_CR28","doi-asserted-by":"publisher","first-page":"13803","DOI":"10.1074\/jbc.272.21.13803","volume":"272","author":"R Yoshida","year":"1997","unstructured":"Yoshida R, Imai T, Hieshima K, Kusuda J, Baba M, Kitaura M, Nishimura M, Kakizaki M, Nomiyama H, Yoshie O. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem. 1997;272:13803\u20139.","journal-title":"J Biol Chem"},{"key":"2640_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","volume":"99","author":"R Forster","year":"1999","unstructured":"Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, Lipp M. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 1999;99:23\u201333.","journal-title":"Cell"},{"key":"2640_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.toxlet.2022.06.003","volume":"366","author":"W Wang","year":"2022","unstructured":"Wang W, Liu E, Li X, Chen S, Pang S, Zhang Y. CCL21 contributes to Th17 cell migration in neuroinflammation in obese mice following lead exposure. Toxicol Lett. 2022;366:7\u201316.","journal-title":"Toxicol Lett"},{"key":"2640_CR31","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.3390\/cells9061420","volume":"9","author":"Y Li","year":"2020","unstructured":"Li Y, Cao T, Ritzel RM, He J, Faden AI, Wu J. Dementia, depression, and associated brain inflammatory mechanisms after spinal cord injury. Cells. 2020;9:1420.","journal-title":"Cells"},{"key":"2640_CR32","doi-asserted-by":"publisher","first-page":"6692802","DOI":"10.1155\/2020\/6692802","volume":"2020","author":"Y Chen","year":"2020","unstructured":"Chen Y, Liang L, Cao S, Hou G, Zhang Q, Ma H, Shi B. Serum CCL21 as a potential biomarker for cognitive impairment in spinal cord injury. Biomed Res Int. 2020;2020:6692802.","journal-title":"Biomed Res Int"},{"key":"2640_CR33","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/imcb.12484","volume":"99","author":"KR Wilson","year":"2021","unstructured":"Wilson KR, Villadangos JA, Mintern JD. Dendritic cell Flt3\u2014regulation, roles and repercussions for immunotherapy. Immunol Cell Biol. 2021;99:962\u201371.","journal-title":"Immunol Cell Biol"},{"key":"2640_CR34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3109\/03009742.2013.809143","volume":"42","author":"M Dehlin","year":"2013","unstructured":"Dehlin M, Bjersing J, Erlandsson M, Andreasen N, Zetterberg H, Mannerkorpi K, Bokarewa M. Cerebrospinal Flt3 ligand correlates to tau protein levels in primary Sjogren\u2019s syndrome. Scand J Rheumatol. 2013;42:394\u20139.","journal-title":"Scand J Rheumatol"},{"key":"2640_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117282","volume":"10","author":"RJ Bishnoi","year":"2015","unstructured":"Bishnoi RJ, Palmer RF, Royall DR. Serum interleukin (IL)-15 as a biomarker of Alzheimer\u2019s disease. PLoS ONE. 2015;10: e0117282.","journal-title":"PLoS ONE"},{"key":"2640_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/ni.2182","volume":"13","author":"HE Liang","year":"2012","unstructured":"Liang HE, Reinhardt RL, Bando JK, Sullivan BM, Ho IC, Locksley RM. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat Immunol. 2012;13:58\u201366.","journal-title":"Nat Immunol"},{"key":"2640_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0411-8","volume":"12","author":"JD Cherry","year":"2015","unstructured":"Cherry JD, Olschowka JA, O\u2019Banion MK. Arginase 1+ microglia reduce A\u03b2 plaque deposition during IL-1\u03b2-dependent neuroinflammation. J Neuroinflam. 2015;12:1\u201313.","journal-title":"J Neuroinflam"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02640-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-022-02640-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02640-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T03:02:53Z","timestamp":1668999773000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-022-02640-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2640"],"URL":"https:\/\/doi.org\/10.1186\/s12974-022-02640-6","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"22 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies and protocols were approved by Boston University School of Medicine, VA Boston Healthcare System, VA Bedford Healthcare System, and Mayo Clinic institutional review boards. Next-of-kin provided written consent for participation and donation. Next-of-kin provided written consent for participation and donation.Consent for publishing","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publishing"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}